number of icap-supported sites by activity, march 2009 (n=839)
DESCRIPTION
Number of ICAP-supported sites by activity, March 2009 (n=839). Number of sites. Number of ICAP-supported sites by country, March 2009 (n=839). Number of sites. What: Collects program and facility information on ICAP-supported care and treatment programs semi-annually - PowerPoint PPT PresentationTRANSCRIPT
Number of ICAP-supported sites by activity, March 2009 (n=839)
Nu
mb
er
of s
ites 839
471 458
266
627
330 331 339
0
100
200
300
400
500
600
700
800
900
Nu
mb
er
of s
ites
Number of ICAP-supported sites by country, March 2009 (n=839)
312
123
79 67 56 56 45 40 30 28 2 10
50
100
150
200
250
300
350
Program and Facility Characteristics Tracking System (PFaCTS)
• What: Collects program and facility information on ICAP-supported care and treatment programs semi-annually
• Purpose: To describe the scope, diversity, and comprehensiveness of ICAP-supported care and treatment programs, and evaluate multi-level factors that influence program performance and patient-level outcomes
Location and type of ICAP-supported HIV care and treatment sites (n=341)
n=192 n=149
% s
ites
27%
72%
65%
27%
8%
0%
50%
100%
Urban Rural
Primary Secondary Tertiary
Proportion of ICAP-supported HIV care and treatment sites offering HIV-related services
on site (n=341)
% s
ites
with
se
rvic
e
92%
85%88%
83%
74%
0%
50%
100%
VCT PMTCT Labor & Delivery TB Treatment ART Pharmacy
Proportion of ICAP-supported HIV care and treatment sites offering HIV-related services on site
by number of services offered (n=341)1 service; 1%
2 services; 4%3 services;
15%
4 services; 31%
5 services; 49%
98%92% 92%
86%80% 78% 77%
70%
50%
39%
0%
50%
100%
Proportion of ICAP-supported HIV care and treatment sites offering ≥4 HIV-related services
on site (n=338)
ICAP Average
=76%
% s
ites
with
≥4
serv
ice
s
98%
57%
33%37%
22%
0%
50%
100%
ART Adherence Support
Outreach Peer educator program
Food support for children and
infants
Food support for adults
Proportion of ICAP-supported HIV care and treatment sites offering on-site patient support
services by type of service offered (n=323)
% s
ites
with
se
rvic
e
Proportion of ICAP-supported HIV care and treatment sites offering on-site patient support services by number of services offered (n=323)
1 Service; 35%
2 Services; 22%
3 Services; 15%
4 Services; 16%
5 Services; 12%
100%
76%
60%
33%
22%20%
4%
0%
50%
100%
Zambia South Africa Rwanda Mozambique Nigeria Kenya Lesotho
Proportion of ICAP-supported HIV care and treatment sites with ≥4 on-site patient support
services (n=241)
% o
f site
s w
ith ≥
4 s
ervi
ces
ICAP Average
=45%
Proportion of ICAP-supported HIV care and treatment sites with access to laboratory assays
(n=342)
% s
ites
35%48% 45%
32%
4% 6%
60%47% 48%
58%
78%
32%
0%
50%
100%
CD4 count Blood Chemistry
LFT CD4 percent Infant Diagnosis /
PCR
HIV-RNA
Available On-Site Available Off-Site
Proportion of ICAP-supported HIV care and treatment sites with access to laboratory assays
by number of assays (n=336)1 assay; 2%
2 assays; 1%
3 assays; 3%
4 assays; 13%
5 assays; 52%
6 assays; 29%
100% 100% 100% 100% 100% 100% 100% 100% 100% 98% 96%
88%
0%
50%
100%
Proportion of ICAP-supported HIV care and treatment sites with access to key HIV-related
laboratory assays (n=342)
% s
ites
ICAP Average
=98%
Proportion of ICAP-supported HIV care and treatment sites with access to PCR laboratory
assays (n=325)
% s
ites
ICAP Average
=92%
100% 100% 100% 100%92% 91% 90% 88%
79% 77%
0%
50%
100%
Mean number of full-time health care providers at ICAP-supported HIV care and treatment sites
(n=348)
Mea
n nu
mbe
r of
pro
vide
rs
0.7
2.6
0.9
3.2
1.51.0
0.5 0.4 0.20.7 1.0
0.1
0.70.8
1.21.3
0.5 0.90.6
0.10.3
0.5
2.0
6.4
4.6
3.0
2.6
2.2
2.41.2
1.50.9
0.30.8
0.80.0
2.0
4.0
6.0
8.0
10.0
Physicians Health Officers / Medical Assistants Nurses
Mean number of outreach workers at ICAP-supported HIV care and treatment sites (n=183)
1.4
3.1
2.0
1.5 1.4 1.4 1.3 1.1
0.70.5
0.3
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
Mea
n nu
mbe
r of
out
reac
h w
orke
rs
Trend in proportion of ICAP-supported HIV care and treatment sites offering on-site patient support services
(n=175)
23%
35%
49%
93%
16%
28%
41%
68%
96%
20%
30%
43%
70%
98%
39%
0%
50%
100%
Food support for adults
Food support for adults or
children
Outreach Adherence Support
Peer educators
Jan-07 Jul-07 Jan-08
% s
ites
Trend in proportion of ICAP-supported HIV care and treatment sites offering prevention services (n=71)
92%95%
92%
78%
63%
19%
94% 96%
84%
78%
67%
31%
0%
50%
100%
Counseling regarding disclosure
Education on behavior and safe
sex
Provision of condoms
Referral for on-site screening for STIs
Education on high-risk substance
abuse
Screening for drug and alcohol abuse
Jul-07 Jan-08
% s
ites
Proportion of ART patients in sub-Saharan Africa that initiated ART at an ICAP-supported site,
December 2007
% o
f all
pa
tient
s o
n A
RT
Sub-S
ahar
an co
untri
es
where
ICAP w
orks
HIV care and treatment services
HIV patients ever enrolled in ICAP supported sites (including closed sites)
HIV patients ever initiating ART in ICAP supported sites (including closed sites)
700,206 337,323
0
50
100
150
200
250
300
350
400
450
500
0
100,000
200,000
300,000
400,000
500,000
600,000
700,000
Sep-04 Sep-05 Sep-06 Sep-07 Sep-08
HIV Care ART Facilities Currently Reporting
Lesotho, RwandaS. Africa, Tanzania
Mozambique
Nigeria,
Zambia
Cote
d’Ivoire
436 sites
613,005 in care
Cumulative enrollment in ICAP-supported HIV care and treatment programs (currently reporting)
298,668on ART
Nu
mb
er o
f p
atie
nts
Nu
mb
er of facilities
Swaziland
0
50
100
150
200
250
300
350
400
450
500
0
10,000
20,000
30,000
40,000
50,000
60,000
70,000
Sep-04 Sep-05 Sep-06 Sep-07 Sep-08
HIV Care ART Facilities Currently Reporting
Cumulative pediatric enrollment in ICAP-supported HIV care and treatment programs (currently reporting)
436 sites
28,031 on ART
Nu
mb
er o
f p
atie
nts
Nu
mb
er of facilities
63,364 in care
Lesotho, RwandaS. Africa, Tanzania
Mozambique
Nigeria,
Zambia
Cote
d’Ivoire
Swaziland
0
100,000
200,000
300,000
400,000
500,000
600,000
700,000
Sep-04 Sep-05 Sep-06 Sep-07 Sep-08
Cumulative enrollment in HIV care in ICAP-supported HIV care and treatment programs by country
(n= 613,005)
Mozambique
South Africa
Ethiopia
Kenya
Tanzania
Rwanda
Lesotho
NigeriaZambia
Cote d’Ivoire
Nu
mb
er o
f p
atie
nts
Swaziland
0
50,000
100,000
150,000
200,000
250,000
300,000
350,000
Sep-04 Sep-05 Sep-06 Sep-07 Sep-08
Mozambique
South Africa
Ethiopia
Kenya
Tanzania
Rwanda
Lesotho
Nigeria Zambia
Swaziland
Nu
mb
er o
f p
atie
nts
Cumulative enrollment on ART at ICAP-supported HIV care and treatment programs by country
(n=298,668)
Cote d’Ivoire
Cumulative person-years on ART at ICAP-supported care and treatment programs, as of March 2009
0
50,000
100,000
150,000
200,000
250,000
300,000
350,000
400,000
Dec-04 Dec-05 Dec-06 Dec-07 Dec-08
Cum
ulat
ive
pers
on-y
ears
on
AR
T
0
50,000
100,000
150,000
200,000
250,000
300,000
350,000
Sep-04 Sep-05 Sep-06 Sep-07 Sep-08
Reported dead
Lost to follow up
Cumulative initiating ART
ART patients retained in care
Cumulative and current enrollment in ART care at ICAP-supported HIV care and treatment programs
as of March 2009 (n= 298,668)
Nu
mb
er
of p
atie
nts
0
50,000
100,000
150,000
200,000
250,000
300,000
350,000
Sep-04 Sep-05 Sep-06 Sep-07 Sep-08
0
100,000
200,000
300,000
400,000
500,000
600,000
700,000
Sep-04 Sep-05 Sep-06 Sep-07 Sep-08
Total care enrollment (n=613,005) Total ART enrollment (n=298,668)
Cumulative enrollment in ICAP-supported HIV care and treatment programs by ART status, age, and sex,
as of March 2009
Men 15+
Women 15+
Children <15 Children <15
Men 15+
Women 15+
49%
99%
61% 59% 56% 55%49% 49%
45% 45%41%
33%
0%
50%
100%
Proportion of patients ever enrolled in HIV care who initiated ART in ICAP-supported care and treatment
programs as of March 2009
% p
atie
nts
initi
atin
g A
RT
n=36,
875
n=
42,0
97
n=6
13,0
05
n=35,
517
n=71,
370
n=2,6
05
n=41,
916
n=5
1,16
9
n=7
9,90
8
n=7
2,05
0
n=1
0,07
3
n=1
76,4
25
n=314,337 n=298,668 n=613,005
Cumulative enrollment in ICAP-supported HIV care and treatment programs by age and sex
as of March 2009
% p
atie
nts
60% 58% 59%
28% 32% 30%
11% 9% 10%
0%
50%
100%
Pre-ART ART Overall
Women 15+ Men 15+ Children <15
59%
69% 67% 66%62% 61% 61% 59% 59% 57% 55%
1%
10%
4% 3%7% 7%
11% 11%9% 11% 11% 9%
99%
0%
50%
100%
Women 15+ Children <15
Cumulative HIV care enrollment of women and children in ICAP-supported HIV care and treatment
programs as of March 2009
% p
atie
nts
in H
IV c
are
n=36
,875
n=
42,0
97
n=6
13,0
05
n=2,
605
n=71
,370
n=41
,916
n=5
1,16
9
n=7
9,90
8
n=7
2,05
0
n=1
0,07
3
n=1
76,4
25
n=3
5,51
7
% p
atie
nts
on A
RT
Cumulative ART enrollment by women and children in ICAP-supported HIV care and treatment programs as
of March 2009
58%
66% 64% 64% 64%61% 60% 58% 58% 56%
53%
1%
9%4% 4%
8% 6% 7%11% 10% 10% 9% 7%
98%
0%
50%
100%
Women 15+ Children <15
n=18
,096
n=
35,1
74
n=2
98,6
68
n=1,
585
n=20
,399
n=22
,989
n=3
2,22
7
n=4
1,02
2
n=4
2,34
4
n=4
,098
n=2
2,99
6
n=5
7,33
8
% p
edi
atr
ic p
atie
nts
in H
IV c
are
Cumulative pediatric HIV care enrollment in ICAP supported HIV care and treatment programs,
as of March 2009
39%
71% 69%
46%37%
23% 23% 19% 19% 15% 14% 12%
23%
14% 13%
24%
23%
23% 27%30% 27%
20%29%
37%
36%
16% 18%
25%40%
53% 45% 51% 54%
48%
57%51%
3% 5% 4%
17%
0%
50%
100%
0-1 year 2-4 years 5-14 years unknown
n=6,391n=1,213n=15,236 n=7,986 n=3,786n=5,374n=9,966 n=4,455 n=97n=63,364 n=5,769 n=3,091
Cumulative pediatric ART enrollment in ICAP-supported HIV care and treatment programs
as of December 2008
% p
edi
atr
ic p
atie
nts
on
AR
T
22%
48%41%
32%
21% 19% 16% 16% 12% 11% 8% 8%
27%
26%
22%29%
22% 28%30% 28%
41%
25%
21%26%
48%
26%
37%32%
57%52%
50% 56%47%
63%
52%
66%
3% 7% 3%
20%
0%
50%
100%
0-1 year 2-4 years 5-14 years unknown
n=2,842n=3,255n=4,990 n=2,409 n=3,460n=680n=4,009 n=1,394 n=3,529n=28,031 n=1,405 n=58
ART initiation among patients eligible for ART in ICAP-supported HIV care and treatment programs,
January-March 2009
% p
atie
nts
elig
ible
for
AR
T
12%
27% 25% 23%
5% 5%
88%
73% 75% 77%
95% 95%100% 100% 100% 100% 100% 100%
0%
50%
100%
% eligible, not started ART % eligible, started ART
n=1,447n=3,058n=5,369 n=2,002 n=376n=680n=3,740 n=2,720 n=285n=25,366 n=2,115 n=3,230
ART regimens distributed in ICAP-supported HIV care and treatment programs,
January-March 2009 Overall (Adults)
N = 162,046 Overall (Children)
N = 19,202
1st line regimen 140,518 (87%) 14,910 (78%)
d4T-3TC-NVP 77,063 (48%) 5,845 (30%)
d4T-3TC-EFV 33,742 (21%) 2,897 (15%)
ZDV-3TC-NVP 19,427 (12 %) 4,336 (23%)
ZDV-3TC-EFV 7,314 (4.5%) 1,034 (5.4%)
Other 2,972 (1.8%) 798 (4.2%)
2nd line regimen 658 (.41%) 281 (1.5%)
Unknown regimen 20,870 (13%) 4,011 (21%)
ART regimens distributed to adults in ICAP-supported HIV care and treatment programs,
January-March 2009
Cote d'Ivoire Ethiopia Kenya Lesotho Mozam-
bique Nigeria Rwanda South
Africa
Swaziland Tanzania Zambia
n=1,436 n=23,856 n=16,572 n=9,206 n=37,470 n=18,578 n=13,977 n=27,481 n= 28,355 n=13,387 n=83
1st line regimen
1,420 23,702 13,829 9,266 34,987 3,137 13,822 26,950 0 13,337 68
(99%) (99%) (83%) (101%) (93%) (17%) (99%) (98%) .00%) (100%) (82%)
2nd line regimen
3 98 73 30 37 43 102 244 0 22 6
(.21%) (.41%) (.44%) (.33%) (.10%) (.23%) (.73%) (.89%) (.00%) (.16%) (7.2%)
Unknown 13 56 2,670 -90 2,446 15,398 53 287 28,355 28 9
(.91%) (.23%) (16%) (-1%) (6.5%) (83%) (.38%) (1.0%) (100%) (.21%) (11%)
* In South Africa, D4T-3TC-LPV/r , ZDV-ddl-LPV/r , and ABC-ddl-LPV/r are prescribed as a first-line regimen for pediatric patients.
ART regimens distributed to children in ICAP-supported HIV care and treatment programs,
January-March 2009
Cote d'Ivoire Ethiopia Kenya Lesotho Mozam-
bique Nigeria Rwanda South
Africa Swaziland Tanzania Zambia
n=53 n=2,123 n=2,248 n=427 n=3,754 n=1,218 n=1,843 n=2,847 n=2,913 n=1,033 n=3,656
1st line regimen
53 2,059 1,992 336 1,833 195 1,802 2,748 0 1,033 2,859
(100%) (97%) (89%) (79%) (49%) (16%) (98%) (97%) (.00%) (100%) (78%)
2nd line regimen
0 12 33 2 3 3 38 64 0 0 126
(.00%) (.57%) (1.5%) (.47%) (.08%) (.25%) (2.1%) (2.2%) (.00%) (.00%) (3.4%)
Unknown 0 52 223 89 1,918 1,020 3 35 2,913 0 671
(.00%) (2.4%) (9.9%) (21%) (51%) (84%) (.16%) (1.2%) (100%) (.00%) (18%)
Proportion of patients with CD4 count at baseline, 6, and 12 months after ART initiation,
as of March 2009
% p
atie
nts
wit
h C
D4
cou
nt 83%
95% 94% 92%
88%
78%74% 73%
66%
44%
72%
59%
47% 49%
32%34%
40%
26%
43%
66%
43%39%
49%
33%
41%44%
30%
0%
50%
100%
Overall Rwanda South Africa Ethiopia Lesotho Nigeria Mozambique Kenya Tanzania
Baseline 6-Month 12-Monthn=7,759n=5,71210,581 n=22,936n=9,162 n=7,682 n=7,153n=97,163 n=26,178
146
198
165 161
137 136124
115106
280
313 314
284 288
264 263256
227
318
353345 342 345
316
287 291279
0
50
100
150
200
250
300
350
400
Overall Rwanda Mozambique Nigeria Tanzania Lesotho Ethiopia South Africa Kenya
Baseline 6-Month 12-Month
Average median CD4 count at baseline, 6 and 12 months after ART initiation, as of March 2009
CD
4 C
ell
Co
unt (
cells
/ul)
134
151 150140 140
128123 122
114
172
207
181175
163
180 181174
155
0
50
100
150
200
250
Overall Tanzania Mozambique South Africa Ethiopia Lesotho Nigeria Kenya Rwanda
6-Month 12-Month
Change in Median CD4 count (cells/µL) at 6 and12 months of ART, as of March 2009
Ch
ang
e in
med
ian
CD
4 co
un
t
Stopped ART 5%
Reported Dead 34%
Lost to Follow-up
62%
Status of ART patients at ICAP-supported HIV care and treatment programs as of March 2009
(n= 298,668)
*Includes patients who transferred out while on ART.
5.9 per 1,000
person-years
51.7 per 1,000
person-years
94.5 per 1,000
person-years
Continued ART243,285
81%
Discontinued ART, 55,383 19%
75% 75%67% 66%
59% 56% 55%47%
31%
23% 25%
27% 31% 41% 44%37%
47%
61%
95%100%
2% 6% 3%8% 6% 8% 5%
0%
50%
100%
Lost to Follow-up Reported Dead Stopped ART
Reasons for ART discontinuation in ICAP-supported HIV care and treatment programs as of
March 2009n=65n=7,787n=6,520 n=1,861n=2,577n=12,335 n=3.202n=7,083 n=5,165 n=8,540 n=248
PMTCT services
Pregnant women counseled and tested inICAP-supported PMTCT programs,
as of March 2009
# o
f Wo
men
482,333456,743
420,518
34,255 24,126
0
100,000
200,000
300,000
400,000
500,000
600,000
1st ANC Counseled Tested HIV Positive ARV prophylaxis
Pregnant women counseled and tested inICAP-supported PMTCT programs
as of March 2009
% W
om
en
95%
87%
8%
65%
0%
50%
100%
Counseled Tested HIV Positive ART Prophylaxis
Pregnant women counseled and tested inICAP-supported PMTCT programs over time
0
10,000
20,000
30,000
40,000
50,000
60,000
70,000
80,000
90,000
Jun-07 Sep-07 Dec-07 Mar-08 Jun-08 Sep-08 Dec-08 Mar-09
1st ANC Counseled Tested HIV Positive ART Prophylaxis
1st ANC 83,677
Counseled 78,956
Tested 74,330
HIV Positive
5,096
ART Prophylaxis
3,739
93%97%
95%97% 98%
95%
89%
95%
79%
84%88% 87%
93%90%
83%
89%
8% 7%9%
13%
6% 8% 7% 8%
63%
82%
56%
36%
75%
86%
76%
66%
0%
50%
100%
Jun-07 Sep-07 Dec-07 Mar-08 Jun-08 Sep-08 Dec-08 Mar-09
Counseled Tested HIV Positive ART Prophylaxis
Pregnant women counseled and tested inICAP-supported PMTCT programs over time
% W
om
en
First ANC n=33,827 n=38.965 n=50,099 n=59,322 n=60,520 n=83,499n=67,608 n=83,577
100% 100% 98% 100%
87% 89%
65%
98%
91% 91%89%
84%
79%
54%
1% 0% 1% 1%
7%
2% 1%
96%
82%
48%
96%
67%
25%
43%
0%
50%
100%
Rwanda Mozambique Nigeria South Africa Lesotho Ethiopia Cote d'Ivoire
Counseled Tested HIV Positive ART Prophylaxis
Pregnant women counseled and tested inICAP-supported PMTCT programs
by country as of March 2009
% W
om
en
First ANC n=42,577 n=124,536 n=9,545 n=7,504n=189,701 n=32,835n=75,619
28%39% 36% 36%
12%4% 4% 1%
60% 40%57% 51%
76%84%
94%
75%
12%21%
7% 12% 12% 12%2%
24%
0%
50%
100%
Overall Nigeria Mozambique Ethiopia Cote d'Ivoire Rwanda South Africa Lesotho
sd-NVP Multi-Drug Regimen initiated ART
Type of ART prophylaxis at ICAP-supported PMTCT programs, as of March 2009
n=10,144 n=738 n=411 n=1,852 n=2,181n=22,154 n=5,484 n=1,344
% W
om
en
n=2,247 n=2,536 n=2,931 n=3,966 n=3,587n=1,216 n=1,932 n=3,739
37% 41%36% 36% 33%
29%22%
11%
48%47% 56% 51% 53% 60%
66%77%
15% 12% 8% 12% 13% 12% 12% 11%
0%
50%
100%
Jun-07 Sep-07 Dec-07 Mar-08 Jun-08 Sep-08 Dec-08 Mar-09
sd-NVP Multi-Drug Regimen initiated ART
Type of ART prophylaxis at ICAP-supported PMTCT programs, April 2007 – March 2009
% W
om
en
TB Screening in HIV Care Settings
The Data: TB Screening in HIV Care Settings
Country Sites supported Sites reporting
Cote d’Ivoire 28 28
Ethiopia 52 46
Kenya 77 77
Mozambique 35 35
Nigeria 66 61
Rwanda 46 46
South Africa 37 26
Swaziland 30 0
Tanzania 87 87
TOTAL 458 406 (89%)
Proportion of new HIV patients screened for TB at enrollment in ICAP-supported HIV care and treatment programs,
January-March 2009
64%
96% 96%
71%68%
59%
51%49%
0%
50%
100%
Overall Rwanda Tanzania Kenya Cote d'Ivoire Nigeria South Africa Mozambique
% p
atie
nts
n=32,731 n=2,215 n=4,018 n=5279 n=2,453n=7,627 n=10,384New HIV patients n=755
90% target
n=8,527 n=14,088 n=17,762 n=18,753New HIV patients n=23,142 n=24,705 n=33,013 n=29,319 n=32,731
Proportion of new HIV patients screened for TB at enrollment in ICAP-supported HIV care and treatment programs
over time
47%53% 53%
63% 64%69%
63%67%
64%
0
200
400
0%
50%
100%
Mar-07 Jun-07 Sep-07 Dec-07 Mar-08 Jun-08 Sep-08 Dec-08 Mar-09
% Screened # Sites Reporting
% p
atie
nts
Proportion of new HIV patients screened for TB at enrollment in ICAP-supported care and treatment
programs over time, by country
0%
50%
100%
Dec-07 Mar-08 Jun-08 Sep-08 Dec-08 Mar-09
Rwanda Tanzania
% p
atie
nts
0%
50%
100%
Dec-07 Mar-08 Jun-08 Sep-08 Dec-08 Mar-09
Kenya Mozambique Nigeria
Proportion of new HIV patients screened for TB at enrollment in ICAP-supported care and treatment
programs over time, by country
% p
atie
nts
0%
50%
100%
Dec-07 Mar-08 Jun-08 Sep-08 Dec-08 Mar-09
Cote d_Ivoire South Africa
Proportion of new HIV patients screened for TB at enrollment in ICAP-supported care and treatment
programs over time, by country
% p
atie
nts
Proportion of HIV patients screened for TB who screened positive at ICAP-supported care and
treatment programs, January-March 2009
22%
59%
35% 33%
17% 17%
11% 10%
0%
50%
100%
Overall South Africa Cote d'Ivoire Mozambique Nigeria Tanzania Rwanda Kenya
n=21,101 n=1,261 n=511 n=5,066 n=2,136n=3,872 n=3,761Patients screened n=4,494
n=3,880 n=366 n=742 n=656 n=1,696 n=177Patients screened positive
n=243
Proportion of new HIV patients with a positive TB screen who initiated TB treatment at ICAP-supported care and treatment programs, January-March 2009
12%
23%
15% 14% 13%9%
3%
0%
50%
100%
Overall Kenya South Africa Tanzania Rwanda Mozambique Cote d'Ivoire
% p
atie
nts
6%10% 9% 8% 6% 5% 4% 3% 1%
0%
50%
100%
Overall Ethiopia Kenya Tanzania Mozambique South Africa Cote d'Ivoire Rwanda Nigeria
New HIV patients n=37,825 n=5,094 n=5,279 n=4,018 n=2,453 n=755n=10,384
Proportion of new HIV patients who initiated TB treatment at ICAP-supported care and treatment
programs, January – March 2009
n=2,215 n=7,627
HIV Testing in TB Clinics
The Data: HIV testing in TB clinics
as of March 2009Country Sites supported Sites reporting
Cote d’Ivoire 9 9
Ethiopia 52 51
Kenya 74 73
Mozambique 36 32
Nigeria 65 61
Rwanda 28 28
South Africa 2 2
TOTAL 266 263 (99%)
93%99% 97%
55%
98%92%
87%
77%
0%
50%
100%
Overall Nigeria Ethiopia South Africa Rwanda Kenya Cote d'Ivoire Mozambique
Proportion of new patients with an unknown HIV status at ICAP-supported TB clinics who were HIV tested, January-March 2009
% p
atie
nts
Tested at any clinicTested at TB clinic
New TB patients w/ unknown HIV
status
n=11,111 n=892 n=6,311 n=436 n=1,882 n=1,084n=282 n=224
Proportion of new TB patients with unknown HIV status at ICAP-supported TB clinics tested for HIV over time
78%
69%
81%
89%83%
90% 93% 94% 95%
0
200
400
0%
50%
100%
Mar-07 Jun-07 Sep-07 Dec-07 Mar-08 Jun-08 Sep-08 Dec-08 Mar-09
% Screened # sites reporting
% p
atie
nts
n=6,597 n=6,333 n=7,053 n=6,694TB patients with unknown HIV
status
n=9,193 n=8,130 n=10,262 n=10,016 n=10,285
18%
50%
28%
5%
44% 43%
36%
22%
0%
50%
100%
Overall South Africa Nigeria Ethiopia Mozambique Rwanda Kenya Cote d'Ivoire
Proportion of HIV tested TB patients at ICAP-supported TB treatment programs who tested positive, January-
March 2009
Tested at any clinicTested at TB clinic
% p
atie
nts
n=10,266 n=240 n=887 n=6,104 n=276 n=195n=835New TB patients tested for HIV
n=1,729
73%
100%
87% 86%
100%
82%
50%
19%
0%
50%
100%
Overall South Africa Nigeria Ethiopia Rwanda Mozambique Kenya Cote d'Ivoire
Proportion of HIV(+) TB patients enrolling in HIV care at ICAP-supported TB treatment programs, January-March 2009
% p
atie
nts
Tested at any clinicTested at TB clinic
n=1,802 n=121 n=246 n=296 n=365 n=42n=120New TB patients testing positive
for HIV
n=612